Resultats globals: 4 registres trobats en 0.02 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
11 p, 1.4 MB Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 / Barbui, Tiziano (Papa Giovanni XXIII Hospital. FROM Research Foundation) ; De Stefano, Valerio (Fondazione Policlinico "A. Gemelli" IRCCS. Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University) ; Alvarez-Larran, Alberto (Hospital Clinic, CIBERehd. Department of Pathology) ; Iurlo, Alessandra (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico. Hematology Division) ; Masciulli, Arianna (Papa Giovanni XXIII Hospital. FROM Research Foundation) ; Carobbio, Alessandra (Papa Giovanni XXIII Hospital. FROM Research Foundation) ; Ghirardi, Arianna (Papa Giovanni XXIII Hospital. FROM Research Foundation) ; Ferrari, Alberto (Papa Giovanni XXIII Hospital. FROM Research Foundation) ; Cancelli, Valeria (Spedali Civili) ; Elli, Elena Maria (ASST Monza. Hematology Division and Bone Marrow Transplant, San Gerardo Hospital) ; Andrade-Campos, Marcio Miguel (Institut Hospital del Mar d'Investigacions Mèdiques) ; Kabat, Mercedes Gasior (Hospital Universitario La Paz (Madrid)) ; Kiladjian, Jean-Jaques (Hospital Saint-Louis) ; Palandri, Francesca (Azienda Ospedaliero-Universitaria di Bologna) ; Benevolo, Giulia (AOU Città della Salute e della Scienza di Torino) ; Garcia-Gutierrez, Valentin (Hospital Ramón y Cajal) ; Fox, Maria Laura (Vall d'Hebron Institut d'Oncologia) ; Foncillas, Maria Angeles (Hospital Universitario Infanta Leonor) ; Morcillo, Carmen Montoya (Complejo Hospitalario Universitario de Albacete) ; Rumi, Elisa (University of Pavia. Department of molecular medicine) ; Osorio, Santiago (Hospital Gregorio Marañón (Madrid)) ; Papadopoulos, Petros (Hospital Clínico San Carlos (Madrid)) ; Bonifacio, Massimiliano (Ospedale Policlinico "G.B. Rossi", Borgo Roma) ; Cervantes, Keina Susana Quiroz (Hospital Universitario de Mostoles) ; Serrano, Miguel Sagues (ICO L'Hospitalet-Hospital Moises Broggi, Sant Joan Despì) ; Carreno-Tarragona, Gonzalo (Hospital Universitario 12 de Octubre (Madrid)) ; Sobas, Marta Anna (Wroclaw Medical University. Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation) ; Lunghi, Francesca (IRCCS Ospedale San Raffaele) ; Patriarca, Andrea (AOU Maggiore della Carità, Novara, Italy) ; Elorza, Begoña Navas (Hospital Moncloa, Madrid, Spain) ; Angona, Anna (Hospital Universitari de Girona Doctor Josep Trueta) ; Mazo, Elena Magro (Hospital Universitario Principe de Asturias) ; Koschmieder, Steffen (RWTH Aachen University. Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine) ; Carli, Giuseppe (Ospedale San Bortolo) ; Cuevas, Beatriz (Hospital Universitario de Burgos) ; Hernandez-Boluda, Juan Carlos (Hospital Clínic Universitari (València)) ; Abadia, Emma Lopez (Hospital General de Elche) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Guglielmelli, Paola (University of Florence. Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi) ; Garrote, Marta (Hospital Clinic, CIBERehd. Department of Pathology) ; Cattaneo, Daniele (Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico. Hematology Division) ; Daffini, Rosa (Spedali Civili) ; Cavalca, Fabrizio (ASST Monza. Hematology Division and Bone Marrow Transplant, San Gerardo Hospital) ; Bellosillo Paricio, Beatriz (Institut Hospital del Mar d'Investigacions Mèdiques) ; Benajiba, Lina (Hospital Saint-Louis) ; Curto-Garcia, Natalia (Guy's and St. Thomas' NHS Foundation Trust) ; Bellini, Marta (ASST Papa Giovanni XXIII, Bergamo, Italy) ; Betti, Silvia (Fondazione Policlinico "A. Gemelli" IRCCS. Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University) ; Harrison, Claire (Guy's and St. Thomas' NHS Foundation Trust) ; Rambaldi, Alessandro (Università degli Studi di Milano) ; Vannucchi, Alessandro Maria (University of Florence. Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi) ; Universitat Autònoma de Barcelona
In a multicenter European retrospective study including 162 patients with COVID-19 occurring in essential thrombocythemia (ET, n = 48), polycythemia vera (PV, n = 42), myelofibrosis (MF, n = 56), and prefibrotic myelofibrosis (pre-PMF, n = 16), 15 major thromboses (3 arterial and 12 venous) were registered in 14 patients, of whom all, but one, were receiving LMW-heparin prophylaxis. [...]
2021 - 10.1038/s41408-021-00417-3
Blood Cancer Journal, Vol. 11 (february 2021)  
2.
7 p, 171.0 KB Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia / Rambaldi, Alessandro (Department of Oncology and Hematology. University of Milan) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Kantarjian, H.M. (Department of Leukemia. University of Texas MD Anderson Cancer Center) ; Dombret, H. (Department of Hematology. Hopital Saint-Louis. Paris Diderot University) ; Ottmann, O.G. (Division of Cancer and Genetics. School of Medicine. Cardiff University) ; Stein, A.S. (Gehr Family Center for Leukemia Research. City of Hope) ; Tuglus, C.A. (Amgen. Inc) ; Zhao, X. (Amgen. Inc) ; Kim, C. (Amgen. Inc) ; Martinelli, G. (Scientific Institute of Romagna for the Study and Treatment of Cancer) ; Universitat Autònoma de Barcelona
Background: A single-arm, phase 2 trial demonstrated the efficacy and safety of blinatumomab, a bispecific T-cell-engaging antibody construct, in patients with relapsed/refractory (r/r) Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), a rare hematologic malignancy with limited treatment options. [...]
2020 - 10.1002/cncr.32558
Cancer, Vol. 126 Núm. 2 (15 2020) , p. 304-310  
3.
13 p, 2.7 MB Minimal residual disease level predicts outcome in adults with Ph-negative Bprecursor acute lymphoblastic leukemia / Gökbuget, Nicola (Department of Medicine II, Department of Hematology/Oncology, University Hospital, Frankfurt, Germany) ; Dombret, Hervé (Hôpital Saint-Louis, Université Paris Diderot) ; Giebel, Sebastian (Maria Sklodowska Curie Memorial Cancer Center, Gliwice) ; Bruggemann, Monika (Department of Hematology and Oncology, University Hospital Schleswig-Holstein) ; Doubek, Michael (Department of Internal Medicine, Hematology and Oncology,University Hospital, Brno, Czech Republic) ; Foà, Robin (Sapienza University of Rome) ; Hoelzer, Dieter (Department of Medicine II, Department of Hematology/Oncology, University Hospital, Frankfurt, Germany) ; Kim, Christopher (Amgen Inc, Thousand Oaks, CA, USA) ; Martinelli, Giovanni (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS) ; Parovichnikova, Elena (National Research Center for Hematology, Moscow) ; Rambaldi, Alessandro (Dipartimento di Oncologia ed Ematologia, Università degli Studi di Milano and Ospedale Papa Giovanni XXIII) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Schoonen, Marieke (Amgen Ltd, London) ; Stieglmaier, Julia M. (Amgen GmBH, Munich) ; Zugmaier, Gerhard (Amgen GmBH, Munich) ; Bassan, Renato (Ospedale dell'Angelo, Mestre-Venezia) ; Universitat Autònoma de Barcelona
Objectives: Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse. This study evaluated outcomes of patients with B-cell precursor ALL with MRD of ≥10−4. [...]
2019 - 10.1080/16078454.2019.1567654
Hematology, Vol. 24 Núm. 1 (2019) , p. 337-348  
4.
11 p, 858.6 KB Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation / Baron, Frédéric (Université de Liège (Bèlgica)) ; Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ; Ruggeri, Annalisa (Hôpital Saint-Louis (Paris, França)) ; Mohty, Mohamad (Hôpital Saint-Antoine (Paris, França)) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Milpied, Noel (Hôpital Haut Léveque (Pessac, França)) ; Bacigalupo, Andrea (Ospedale Sant Martino (Genova, Itàlia)) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII (Bergamo, Itàlia)) ; Bonifazi, Francesca (Policlinico Sant'Orsola-Malpighi (Bologna, Itàlia)) ; Bosi, Alberto (Azienda Ospedaliero Universitaria Careggi (Firenze, Itàlia)) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Yakoub-Agha, Ibrahim (Hôpital Claude Huriez (Lille, França)) ; Ribera Santasusana, J. M. (José María) (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gluckman, Eliane (Hôpital Saint-Louis (Paris, França)) ; Nagler, Arnon (Sheba Medical Center (Ramat Gran, Israel)) ; Universitat Autònoma de Barcelona
BACKGROUND: In the setting of allogeneic human leukocyte antigen (HLA)-matched bone marrow transplantation, transplanting male patients with grafts from female donors has been associated with a higher incidence of graft-versus-host disease (GVHD) and of nonrelapse mortality (NRM). [...]
2015 - 10.1186/s13045-015-0207-4
Journal of hematology & oncology, Vol. 8 Núm. 107 (october 2015)  

Vegeu també: autors amb noms similars
1 Rambaldi, A.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.